January 2017

January 27, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA) (“Alliance Growers” or the “Company”) is pleased to provide an update on the Company’s planned equity investment to finance Canna Companion Products, Inc. (“Canna”). Canna is a wholly owned subsidiary of WFS PharmaGreen Inc. (“Pharmagreen”) that produces and sells whole-plant hemp pet supplements. Canna, a Washington State incorporated company, is the manufacturing, fulfillment and sales centre for the Canna products.  For further information, see www.cannacompanionusa.com.

 

Further to an announcement dated November 15, 2016, Alliance Grower’s strategic investment in Canna Companion is via its parent, Pharmagreen. The arrangement calls for Alliance Growers to invest CAD$300,000 on favourable financial terms with regard to pricing and warrants, in return for an exclusive long term (“Cannabinoid”) CBD oil supply contract when Canna expands to the Canadian market, planned for later 2017.

 

Commenting on the equity investment, Dennis Petke, Alliance Growers President and CEO said, “The opportunity for Alliance Growers to make this strategic investment in Canna provides two great benefits. First is the investment opportunity.  Canna has already shown tremendous success in the lucrative cannabis pet product market and is poised for spectacular growth. The second is the Agreement giving Alliance Growers the exclusive CBD oil supply contract from Canna in Canada.”

 

Pharmagreen is currently a private company incorporated under the business act of British Columbia.  The company is in the process of making application for a listing on the OTCBB-QB as a reporting filer.  Pharmagreen’s management is targeting to have this process completed during 2017.

 

Pharmagreen owns the worldwide rights to its cannabis science based proprietary supplement formulation geared towards pets and animals, licensed to Canna.  Their formulation was based on over fifteen years of research and development by two Doctorates of Veterinary Medicine.  These two DMV’s form part of the management and research and development teams.  The formulation and products are veterinary formulated and veterinarian approved.

 

Since the official sales launch of the Canna products for cats and dogs on February 1, 2016, monthly net sales reached the US$100,000 milestone for the month of November, 2016, with Canna net sales of approximately US$941,500 for the 11 month period ending December 31 2016. Also, Canna Companion is currently conducting research and development of whole-plant hemp based products for the animal world.

 

About Alliance Growers

Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic MMPR Investments, CBD Oil Supply and Distribution, and Research and Development.

Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with existing MMPR licensed and soon-to-be licensed facilities.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobGrace@alliancegrowers.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.


January 23, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG) (“Alliance Growers” or the “Company”) is pleased to announce the Company principal terms of the agreements with Botanical Research In Motion International Inc. (“B.R.I.M.”) for: (i) an exclusive license to use B.R.I.M.’s proprietary technology for large commercial scale micro propagation of cannabis plantlets, and (ii) a consulting agreement to provide B.R.I.M.’s expertise.  These agreements were ratified by the Board of Directors of the Company on January 22, 2017.

As disclosed in news releases on October 26, 2016 and November 7, 2016, Alliance Growers had entered into a Memorandum of Understanding (“MOU”) with B.R.I.M. whereby B.R.I.M. would grant a license that will allow Alliance Growers to jointly develop and operate multiple cannabis focused Botany Centres in Canada. Alliance Growers and B.R.I.M. have executed a definitive Exclusive License Agreement and corresponding Consulting Services Agreement whereby B.R.I.M. has granted Alliance Growers an Exclusive License to devlop Cannabis Botany Centres in Canada.

B.R.I.M. projects the development of the Cannabis Botany Centre will add value to Alliance Growers by providing the following:

  • R.I.M. forecasts the potential for the Botany Centre to produce in excess of three million cannabis plantlets per year with a potential margin of $4 per plantlet;
  • Generate revenue from the extraction, processing and resale of cannabidiol (CBD) oil in Canada, USA and offshore, potentially several million dollars per year;
  • Providing cold storage facilities utilizing the one-of-a-kind Cryotissue Cold Storage technology for tissue culture preservation and regeneration as needed on long term basis.
  • Provide extraction services as retail services for cultivators and create custom profiles for extraction of botanicals oils for the retail market.

Commenting on the Definitive Agreement, Dennis Petke, Alliance Growers President and CEO said, “We are very pleased to have executed these agreements so that we can now purchase the property upon which we will build the Cannabis Botany Centre. As part of Alliances business model, we have begun negotiating with growers at various stages in the license process to purchase interests in their operations in exchange for long term supply plantlet supply contracts and offtake agreements, even before the Centre is built.  This guarantees immediate sales which will continue well into the future.  In addition to the services offered by the Cannabis Botany Centre, BRIM and Alliance have identified significant additional revenue streams in the Medical and Cannabis space that we are very excited to begin implementing after we complete this current round of funding.”

Mr. Petke continued, “Alliance continues to develop its business model to take advantage of the imminent legalization of Recreational Cannabis in Canada as well as the existing stets that have legalized Cannabis in the US.  We would like to thank our existing shareholders and all new investors for their continued support as we work towards realizing our vision of becoming a successful global cannabis company”.

The Exclusive License Agreement includes the following significant terms:

Exclusive License Agreement

In consideration of the granting of this Exclusive License, Alliance Growers will pay to B.R.I.M. the following:

  1. Issue to B.R.I.M. a total of 6,000,000 common shares and 3 million warrants to be released in stages.
  2. Cash payments of $75,000 on execution of the MOU (paid) and $25,000 on execution of the Definitive Agreement and $50,000 on Closing, on or berfore February 28, 2017
  3. Pay a Royalty to B.R.I.M. of 5% of gross sales for each month, provided however that payment will not be made where it would result in an operating loss unless gross sales exceed $100,000 each month.
  4. Closing will be subject to completion of all due diligence by January 31, 2017 and Alliance Growers raising a minimum of $2,000,000.
  5. R.I.M. has a first right of refusal to acquire the land and Botany Centre if Alliance is unable to compete construction at a price equal to the greater of fair market value and all expenses incurred by Alliance

Concurrent with execution of the Exclusive License Agreement, Alliance and B.R.I.M. have entered into a Consulting Agreement and the usual Non-Disclosure Agreement pertaining to the Proprietary Technology.

 

Consulting Agreement

This agreement is about B.R.I.M.’s duties and compensation. The principle terms are as follows:

  • one year renewable term.
  • Advise during the pre-construction phase of the Botany Centre, planning of the location and assistance in the application for zoning and building permits.
  • Supervise the construction and engineering according to the specifications in the Work Agreement.
  • assist in all phases of the construction of a Botany Centre in the lower mainland of British Columbia.
  • assist Alliance Growers in its applications to obtain appropriate permits from Health Canada in order for the Botany Centre to legally produce and extract cannabis products and sell them.
  • assist Alliance Growers to manage and operate the Botany Centre

Alliance Growers shall accrue a consulting fee payable to BRIM at the rate of $3,000 per month, commencing January 17, 2017 until January 31, 2017.

Thereafter, Alliance Growers shall pay BRIM a consulting fee of $6,000 CDN per month, commencing February 1, 2017, for the duration of the pre-construction phase until the completion of the acquisition of the property for the Botany Centre (the “Property”). These fees may be accrued until the Botany Centre is fully permitted and licensed for commercial production and commercial sale of cannabis products.

Upon acquisition of the Property and completion of all building plans, including all engineering and permitting and the receipt of all licenses and permits required to operate the Botany Centre (“Approvals”) (excluding  MMPR or comparable license from Health Canada), Alliance Growers shall enter into contracts with BRIM for the provision of the necessary management services as agreed to by both parties to construction completion, in any case not to exceed $18,000 per month. Monthly fees in excess of $12,000 shall be accrued until the Botany Centre is fully permitted and licensed for commercial production and commercial sale of cannabis products.

Upon receipt of the MMPR or comparable License from Health Canada Alliance Growers shall enter into contracts with BRIM for the provision of the necessary management services as agreed to by both parties for the management of the Botany Centre, based on commercial rates of pay for work performed.  All other personnel will be hired or contracted directly by Alliance Growers, or its wholly owned subsidiary.

Right of First Refusal (“ROFR”)

Brim has the ROFR to purchase the Botany Centre prior to completion of construction if the Corporation cannot complete the construction of the Botany Centre. The purchase price will be the greater of (i) fair market value as determined by the Alliance’s professional advisors and (ii) not less than input costs expended or owing by Alliance in acquiring the Lands and all costs of designing, developing and building the Botany Centre to the date of purchase plus Alliance’s borrowing costs if any.

Non-Disclosure Agreements

Brim and the Company have signed agreements to protect their confidential information.

Future Employment Agreement

The Company has signed an agreement with Brim and its chief scientist, Dr. Fawzia Afreen, that in the event she ceases employment with Brim that she can be employed directly by Alliance Growers.

An arms-length finders’ fee shall be payable in cash and/or shares in the amount of $68,250 equal to 10% of the first $300,000 and 7.5% on the remainder of the deemed value of the acquisition of $810,000 to David J. Kwiatkowski, Vancouver, B.C.

About Alliance Growers

Alliance Growers Corp (ACG: CSE) is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – MMPR cannabis production facilities, distribution network, consumer products, and research and development.

Alliance Growers has excuted an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.  The Cannabis Botany Centre will feature:

1 – B.R.I.M.’s proprietary “Chibafreen Invitro Plant Production System”

Utilizing its proprietary state of art clean tissue culture lab room which, according to BRIM, is designed to produce over three million Tissue Culture Plantlets per year.  The design is scalable and designed for all flora to serve the entire agriculture industry.

2 – B.R.I.M.’s proprietary Cryotissue Cold Storage

Utilizing the one-of-a-kind Cryotissue Cold Storage technology for tissue culture preservation and regeneration as needed on long term basis.

3 – Extraction Lab

Provide custom profiles for extraction for botanicals oils for retail market.

Provide extraction services as retail services to cultivators.

4 – Botanical DNA Services Laboratory

Certifying plant tissue at the genetic level.

Additional DNA mapping services.

5 – B.R.I.M’s proprietary research for cannabis for large commercial scale micro propagation production when permitted.

Further, Alliance Growers has announced an agreement to a strategic investment arrangement with PharmaGreen and Canna Companion with offtake rights and agreements with both entities. As well, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with existing MMPR licensed and soon-to-be licensed facilities.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

For more information contact:

 Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobGrace@alliancegrowers.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 


January 18, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG) (the “Company”) announces that it has increased the numbers of units being offered pursuant to a non-brokered private placement (the “Private Placement”) announced November 8, 2016.  The offering has been increased from 10,000,000 units (the “Units”) at a price of $0.20 per Unit, to a maximum of 15,000,000 Units for gross proceeds of up to $3,000,000.

Each Unit is comprised of one common share and one share purchase warrant. Each share purchase warrant will entitle the holder to acquire one additional common share in the capital of the Company at a price of $0.30 per share, for a period of two years from the date the Units are issued. If during the exercise period of the warrants, but after the resale restrictions on the shares have expired, the Company’s shares trade at or above a weighted average trading price of $0.45 per share for 10 consecutive trading days, the Company may accelerate the expiry time of the warrants by giving written notice to warrant holders that the warrants will expire 30 days from the date of providing such notice.

A portion of the Private Placement may be completed in accordance with the exemption set out in BC Instrument 45-534 (Exemption from prospectus requirement for certain trades to existing security holders) (the “Security Holder Exemption”) pursuant to the terms and conditions of this Offering News Release and BC Instrument 45-534.  Alliance shall make the pro-rata offer available to all persons who, as of the record date of November 7, 2016, held common shares in the capital of the Company.  In accordance with the requirements of the Security Holder Exemption, the Company confirms there is no material fact or material change related to the Company which has not been generally disclosed.

The Private Placement securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “1933 Act”), or under any state securities laws, and may not be offered or sold, directly or indirectly, or delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the 1933 Act) absent registration or an applicable exemption from the registration requirements. This news release does not constitute an offer to sell or a solicitation to buy such securities in the United States.

The Company plans to allocate the proceeds of the Private Placement primarily to the Botany Centre for property acquisition and preliminary planning and development, plus Investments in Licensed Growers and at various stages of the license process, investments in other potentially lucrative arrangements in the medical and recreational cannabis space, as well as general working capital. The financing is subject to regulatory approval.  All securities issued pursuant to the placement will be subject to a hold period of four months and one day from the date of closing.

The Board of Directors has been advised that the January 3, 2017 press release was in contravention of Canadian Securities Exchange Policy, where announced Options were priced incorrectly, as they may not be granted at a discount, but rather the higher of the closing price the day before, or the closing price the day of the grant.

The Company has adjusted the pricing for the grant to $0.185 for 1,750,000 options to directors, officers and consultants of the Company, which options are exercisable into common shares of the Company at a price of $0.185 per share. Subject to the rules of the Canadian Securities Exchange and the Company’s Stock Option Plan, the options have a term of five years and will expire on January 2, 2022.  At the time of the grant closing price of Alliance common shares was $0.185.

About Alliance Growers Corp.

Alliance Growers is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – MMPR cannabis production facilities, distribution network, consumer products, and research and development.

Alliance has finalized a Definitive License Agreement with B.R.I.M. for a Canada Exclusive License to jointly develop and operate cannabis Botany Centres.  The initial project is planned as a staged development of a 40,000 square foot facility being located near Vancouver, B.C., to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the cannabis market and agriculture market in general.  The planned facility will grow cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.  As well, Alliance Growers is negotiating to obtain exclusive Canadian distribution agreements for certain proprietary products for support of the cannabis growing industry in addition to possible partnerships with existing MMPR licensed and soon-to-be licensed facilities.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

 

For more information contact:

 

Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 

Rob Grace

Corporate Communications

Tel: 778-998-5431

RobGrace@alliancegrowers.com

 

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.


January 17, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG) (“Alliance Growers” or the “Company”) is pleased to announce that the Company has finalized its agreements with Botanical Research In Motion International Inc. (“B.R.I.M.”) for: (i) an exclusive license to use B.R.I.M.’s proprietary technology for large commercial scale micro propagation of cannabis plantlets, and (ii) a consulting agreement to provide B.R.I.M.’s expertise.

B.R.I.M. will advise regarding Alliance’s proposed 40,000 square foot “Cannabis Botany Centre” to service the Cannabis market specifically and the agriculture market in general.

The Alliance board of directors are meeting Tuesday, January 17, 2017 to approve the B.R.I.M. agreements.

A detailed news release will be issued Wednesday January 18, 2017 setting out the principal terms of both agreements. The final terms are not substantially different than those previously announced. In news releases on October 26, 2016 and November 7, 2016, Alliance Growers has entered into a Memorandum of Understanding (“MOU”) with Botanical Research In Motion International Inc. (“B.R.I.M.”) whereby B.R.I.M. will grant a license that will allow Alliance Growers to jointly develop and operate multiple cannabis focused Botany Centres in Canada and will include the following:

1 – B.R.I.M.’s proprietary “Chibafreen Invitro Plant Production System”

Utilizing its proprietary state of art clean tissue culture lab room designed to produce over one million Tissue Culture Plantlets per year.  The design is scalable and designed for all flora to serve the entire agriculture industry.

2 – B.R.I.M.’s proprietary Cryotissue Cold Storage

Utilizing the one-of-a-kind Cryotissue Cold Storage technology for tissue culture preservation and regeneration as needed on long term basis.

3 – Extraction Lab

Provide custom profiles for extraction for botanicals oils for retail market.

Provide extraction services as retail services to cultivators.

4 – Botanical DNA Services Laboratory

Certifying plant tissue as the genetic level.

Additional DNA mapping services.

5 – B.R.I.M’s proprietary research for cannabis for large commercial scale micro propagation production when permitted.

About Alliance Growers

Alliance Growers Corp (ACG: CSE) is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – MMPR cannabis production facilities, distribution network, consumer products, and research and development.

Alliance Growers is finalizing an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed facility will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.

Further, Alliance Growers has announced an agreement to a strategic investment arrangement with PharmaGreen and Canna Companion with offtake rights and agreements with both entities. As well, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with existing MMPR licensed and soon-to-be licensed facilities.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

 

For more information contact:

 

Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 

Rob Grace

Corporate Communications Consultant

Tel: 778-998-5431

RobGrace@alliancegrowers.com

 

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

FORWARD LOOKING INFORMATION

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

 

 

 


ALLIANCE GROWERS FILES ITS AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED AUGUST 31, 2016 AND APPOINTS A NEW DIRECTOR

January 13, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG) (the “Company”) announces that the has filed on SEDAR its audited consolidated financial statements for the year ended August 31, 2016, together with the auditors’ report as well as the MD&A and officers’ certificates. The Company is awaiting the revocation of the January 5, 2017 Cease Trade Order by the BCSC and OSC.    The delay in finalizing the financial statements was to deal with unjustified claims against the Company arising from consulting agreements dated prior to current management’s involvement, which were never approved by the prior board of directors. The Company was able to satisfy the auditor’s queries and the claims were set up as contingent liabilities only. See http://www.sedar.com/DisplayProfile.do?lang=EN&issuerType=03&issuerNo=00036417

Appointment of a New Director

The Company is pleased to announce the appointment of Ian Lambert to the Board of Directors of the Company on January 9, 2017.  Mr. Lambert, who has been serving as Strategic Advisor on the Advisory Board for the past year, has over 30 years’ experience managing public companies as a CEO, Director, and Chair of Audit and Corporate Governance Committees.

The Board of Directors now consists of Dennis Petke (CEO), Rupert Shore, Sina Pirooz and Ian Lambert. The audit committee is comprised of Dennis Petke, Rupert Shore and Ian Lambert.

Dennis Petke, Alliance Growers CEO stated “We appreciate our many supporters’ and investors’ patience as we completed the annual audit.  Now that it is filed, we are back focusing on the finalization of the previously announced Exclusive License Agreement with BRIM for the development of our Cannabis Botany Centre.  We, as management and stockholders as well, want our supporters to know we are fully committed to completing our plans as expeditiously as possible, while at the same time maximizing the opportunity and mitigating risks.  We believe we will all benefit from this careful, prudent approach in the long term”.

About Alliance Growers Corp.

Alliance Growers is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – MMPR cannabis production facilities, distribution network, consumer products, and research and development.

Alliance is final stages of executing a Definitive License Agreement with B.R.I.M. for a Canada Exclusive License to jointly develop and operate cannabis Botany Centres.  The initial project is planned as a staged development of a 40,000 square foot facility being located near Vancouver, B.C., to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the cannabis market and agriculture market in general.  The planned facility will grow cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.  As well, Alliance Growers is negotiating to obtain exclusive Canadian distribution agreements for certain proprietary products for support of the cannabis growing industry in addition to possible partnerships with existing MMPR licensed and soon-to-be licensed facilities.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

 

For more information contact:

 

Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 

Rob Grace

Corporate Communications

Tel: 778-998-5431

RobGrace@alliancegrowers.com

 

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

 


January 9, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG) (the “Company”) announces the status of the Suspension of Trading on the Canadian Securities Exchange.  Pursuant to a Section 164 Cease Trade Order issued by the British Columbia Securities Commission on January 3, 2017, the Company is required to file the August 31, 2016 audited annual financial statements, corresponding MD&A and CEO/CFO certifications, in order to comply with Securities legislation.

Due to claims made by former contractors for unauthorized payments not approved by the former Board of Directors, the clarification of this issue has caused considerable delay in the finalization and sign-off by the auditors of the August 31, 2016 annual Financial Statements.  Current management disputes the amounts claimed and intends to defend its position that these do not constitute liabilities of the Company.

Management has been advised by the auditors that they have accepted the position of the Company, and the finalization and filing on SEDAR of the the audited annual financial statements, corresponding MD&A and CEO/CFO certifications as at August 31, 2016 is anticipated to be completed on Tuesday January 10, 2017.

About Alliance Growers Corp.

Alliance Growers is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – MMPR cannabis production facilities, distribution network, consumer products, and research and development.

Alliance is finalizing a Definitive License Agreement with B.R.I.M. for a Canada Exclusive License to jointly develop and operate cannabis Botany Centres.  The initial project is planned as a staged development of a 40,000 square foot facility being located near Vancouver, B.C., to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the cannabis market and agriculture market in general.  The planned facility will grow cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.  As well, Alliance Growers is negotiating to obtain exclusive Canadian distribution agreements for certain proprietary products for support of the cannabis growing industry in addition to possible partnerships with existing MMPR licensed and soon-to-be licensed facilities.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

 

For more information contact:

 

Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 

Rob Grace

Corporate Communications

Tel: 778-998-5431

RobGrace@alliancegrowers.com

 


January 3, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG) (the “Company”) announces that the Board of Directors has approved the grant of 1,750,000 options to directors, officers and consultants of the Company, which options are exercisable into common shares of the Company at a price of $0.12 per share. Subject to the rules of the Canadian Securities Exchange and the Company’s Stock Option Plan, the options have a term of five years and will expire on January 2, 2022.  At the time of the grant the prior days’ closing price of Alliance common shares was $0.15.

About Alliance Growers Corp.

Alliance Growers is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – MMPR cannabis production facilities, distribution network, consumer products, and research and development.

Alliance is finalizing a Definitive License Agreement with B.R.I.M. for a Canada Exclusive License to jointly develop and operate cannabis Botany Centres.  The initial project is planned as a staged development of a 40,000 square foot facility being located near Vancouver, B.C., to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the cannabis market and agriculture market in general.  The planned facility will grow cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.  As well, Alliance Growers is negotiating to obtain exclusive Canadian distribution agreements for certain proprietary products for support of the cannabis growing industry in addition to possible partnerships with existing MMPR licensed and soon-to-be licensed facilities.

For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.

If you would like to be added to Alliance Growers’ news distribution list, please send your email address to newsletter@alliancegrowers.com

On behalf of the board of directors of

ALLIANCE GROWERS CORP.

“Dennis Petke”

Dennis Petke

President and CEO

 

For more information contact:

 

Dennis Petke

Tel: 778-331-4266

DennisPetke@alliancegrowers.com

 

Rob Grace

Corporate Communications

Tel: 778-998-5431

RobGrace@alliancegrowers.com